ELI LILLY & Co — Director's Dealing 2023

Jul 3, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2023-06-30

Reporting Person: LILLY ENDOWMENT INC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-06-30	Common Stock	S	12244	$465.515	Disposed	101180691	Direct
2023-06-30	Common Stock	S	29938	$466.572	Disposed	101150753	Direct
2023-06-30	Common Stock	S	58847	$467.561	Disposed	101091906	Direct
2023-06-30	Common Stock	S	54269	$468.408	Disposed	101037637	Direct
2023-06-30	Common Stock	S	8827	$469.219	Disposed	101028810	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $465.00 to $465.995, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4) and (5) to this Form 4.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $466.00 to $466.995, inclusive.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $467.00 to $467.995, inclusive.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $468.00 to $468.99, inclusive.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $469.00 to $469.72, inclusive.